Sánchez-Díaz, M.
Flórez, Á.
Ara-Martín, M.
Arias-Santiago, S.
Botella-Estrada, R.
Cañueto, J.
Carretero-Hernández, G.
Coto-Segura, P.
de Eusebio-Murillo, E.
García-Latasa de Araníbar, F.J.
García-Patos Briones, V.
Gardeazabal García, J.
Gómez-Fernández, C.
Hernández-Ostiz, S.
Izu Belloso, R.
López-Ávila, A.
Manchado López, P.
Martín-Santiago, A.
Martinez de Espronceda Ezquerro, I.
Mateu-Puchades, A.
Mercader-García, P.
Notario Rosa, J.
Palacio Aller, L.
Pérez-Hortet, C.
Quintana-Castanedo, L.
Rivera, R.
Rocamora Duran, V.
Rodríguez-Nevado, I.M.
Ruiz-Villaverde, R.
Suárez, J.
Trasobares-Marugán, L.
Vizán-de Uña, C.
Yanguas, I.
Zulaica-Garate, A.
García-Doval, I.
Descalzo, M.Á.
Grau-Pérez, M.
Carrascosa-Carrillo, J.M.
This article is maintained by: Elsevier
Article Title: [Translated article] Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study
Journal Title: Actas Dermo-Sifiliográficas
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ad.2024.01.019
CrossRef DOI link to the associated document: https://doi.org/10.1016/j.ad.2023.10.016
Content Type: article
Copyright: © 2023 AEDV. Published by Elsevier España, S.L.U.